Shuan Rao

11.3k total citations · 2 hit papers
50 papers, 3.9k citations indexed

About

Shuan Rao is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuan Rao has authored 50 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuan Rao's work include Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Muscle metabolism and nutrition (5 papers). Shuan Rao is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Gastric Cancer Management and Outcomes (6 papers) and Muscle metabolism and nutrition (5 papers). Shuan Rao collaborates with scholars based in China, United States and United Kingdom. Shuan Rao's co-authors include Chengyu Jiang, Josef Penninger, Feng Guo, Keiji Kuba, Yumiko Imai, Xiaozhong Peng, Yi Huan, Michael A. Crackower, Renu Sarao and Teiji Wada and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

Shuan Rao

47 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiotensin-converting enzyme 2 protects from severe acute lung failure

2005 1.8k citations Shuan Rao, Chengyu Jiang et al. profile →
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation

2020 530 citations Tao Liu, Qinglv Wei et al. Nucleic Acids Research profile →

Peers

Countries citing papers authored by Shuan Rao

Since Specialization

Citations

This map shows the geographic impact of Shuan Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuan Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuan Rao more than expected).

Fields of papers citing papers by Shuan Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuan Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuan Rao. The network helps show where Shuan Rao may publish in the future.

Co-authorship network of co-authors of Shuan Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Shuan Rao. A scholar is included among the top collaborators of Shuan Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuan Rao. Shuan Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Jaceosidin overcomes osimertinib resistance in lung cancer by inducing G2/M cycle arrest through targeting DDB1	Toxicology and Applied Pharmacology	Zhuoying Yang, Yingying Liu et al.	1
2	Human Pluripotent Stem Cell-Derived Alveolar Organoids for Gene-editing and Lung Adenocarcinomas Modeling	International Journal of Biological Sciences	Lian Li, Yuchen Liu et al.	0
3	Impact of nutritional status on pathological response and recurrence-free survival in locally advanced oesophagogastric adenocarcinoma treated with perioperative FLOT therapy	PubMed	Keiji Sugiyama, A Chaudry et al.	0
4	Remodelin delays non‐small cell lung cancer progression by inhibiting NAT10 via the EMT pathway	Cancer Medicine	Quanwei Guo, Weijun Yu et al.	8
5	Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE	ESMO Open	Susanna Slater, Claire Saffery et al.	4
6	SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming	Nature Cell Biology	Xi Xu, Yanhui Yu et al.	25
7	A Phase 1 Trial of the Safety, Tolerability, and Biological Effects of Intravenous Enadenotucirev (EnAd), a Novel Oncolytic Virus, in Combination with Chemoradiotherapy in Locally Advanced Rectal Cancer (CEDAR)	International Journal of Radiation OncologyBiologyPhysics	Séan M. O’Cathail, Meng Qiao et al.	1
8	Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer	Science Translational Medicine	Shane J. F. Cronin, Shuan Rao et al.	21
9	Effect of aerobic exercise on lung regeneration and inflammation in mice	Immunobiology	Zheng Zhang, Shuan Rao et al.	2
10	Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer	Translational Lung Cancer Research	Jianjun Yang, Hua Wu et al.	8
11	The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation breakdown →	Nucleic Acids Research	Tao Liu, Qinglv Wei et al.	530
12	Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade	Frontiers in Oncology	Jianjun Yang, Xiguang Liu et al.	119
13	A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models	Acta Pharmaceutica Sinica B	Jing Jin, Nina Xue et al.	28
14	Multiplatform assay to classify formalin-fixed paraffin-embedded (FFPE) colorectal cancer (CRC) samples into molecular subtypes with mutational profiles	Annals of Oncology	Elisa Fontana, Chanthirika Ragulan et al.	1
15	RANKL and RANK: From Mammalian Physiology to Cancer Treatment	Trends in Cell Biology	Shuan Rao, Shane J. F. Cronin et al.	65
16	Autophagy in non-small cell lung carcinogenesis	Autophagy	Shuan Rao, Heng Yang et al.	53
17	Molecular pathogenesis of severe acute respiratory syndrome	Microbes and Infection	Hongliang Wang, Shuan Rao et al.	11
18	External Beam Radiotherapy and Intraluminal Brachytherapy in Advanced Inoperable Esophageal Cancer	American Journal of Clinical Oncology	Shuan Rao et al.	8
19	Phase I study of irinotecan and raltitrexed in patients with advanced astrointestinal tract adenocarcinoma	British Journal of Cancer	Hugo Ford, David Cunningham et al.	21
20	Human skeletal muscle debranching enzyme activities with exercise and training	European Journal of Applied Physiology	Anne Taylor, Robert E Thayer et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact